These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 17030765)
21. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Abdel-Wahab OI; Healy B; Dzik WH Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060 [TBL] [Abstract][Full Text] [Related]
22. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Yasaka M; Minematsu K; Naritomi H; Sakata T; Yamaguchi T Thromb Haemost; 2003 Feb; 89(2):278-83. PubMed ID: 12574807 [TBL] [Abstract][Full Text] [Related]
23. [Warfarin treatment and bleeding]. Breen AB; Vaskinn TE; Reikvam A; Skovlund E; Lislevand H; Madsen S Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1835-7. PubMed ID: 12830257 [TBL] [Abstract][Full Text] [Related]
24. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Brody DL; Aiyagari V; Shackleford AM; Diringer MN Neurocrit Care; 2005; 2(3):263-7. PubMed ID: 16159073 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage. Siddiq F; Jalil A; McDaniel C; Brock DG; Pineda CC; Bell RD; Lee K Neurocrit Care; 2008; 8(1):36-41. PubMed ID: 17898941 [TBL] [Abstract][Full Text] [Related]
26. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107 [TBL] [Abstract][Full Text] [Related]
27. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. Gonzalez EA; Moore FA; Holcomb JB; Miller CC; Kozar RA; Todd SR; Cocanour CS; Balldin BC; McKinley BA J Trauma; 2007 Jan; 62(1):112-9. PubMed ID: 17215741 [TBL] [Abstract][Full Text] [Related]
28. Bleeding risks and response to therapy in patients with INR higher than 9. Pagano MB; Chandler WL Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709 [TBL] [Abstract][Full Text] [Related]
36. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results. Holland LL; Brooks JP Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596 [TBL] [Abstract][Full Text] [Related]
37. Mild elevations of international normalized ratio at hospital Day 1 and risk of expansion in warfarin-associated subdural hematomas. Roguski M; Wu K; Riesenburger RI; Wu JK J Neurosurg; 2013 Oct; 119(4):1050-7. PubMed ID: 23581582 [TBL] [Abstract][Full Text] [Related]
38. What to do when warfarin therapy goes too far. Prasad S; Wootten MR; Kulinski N; Chapman SA J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771 [TBL] [Abstract][Full Text] [Related]
39. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Kuwashiro T; Yasaka M; Itabashi R; Nakagaki H; Miyashita F; Naritomi H; Minematsu K Cerebrovasc Dis; 2011; 31(2):170-6. PubMed ID: 21135553 [TBL] [Abstract][Full Text] [Related]
40. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism. Magee G; Peters C; Zbrozek A Clin Ther; 2013 Sep; 35(9):1432-43. PubMed ID: 23954093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]